Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus
{{output}}
Monoclonal antibodies (mAbs) have revolutionized the selective targeting of disease, as well as changing the character of the pharmaceutical industry. Although most attention has focused on conventional antibodies, immunoconjugates and bispecific antibodies (b... ...